Which hedge funds own LTRN? LANTERN PHARMA INC, Q2 2026 13F holders

6 tracked hedge funds disclosed a position in LTRN (LANTERN PHARMA INC) in their Q2 2026 13F filings, worth $7.2m in total. The largest holder by portfolio weight is Empery Asset Management, LP at 4.1% of its book. 3 opened a new position this quarter: Empery Asset Management, LP, Citadel Advisors LLC, Marshall Wace, LLP. 1 exited: Voss Capital, LP.

6

Holders

Tracked managers whose filing for the quarter reports a long equity position in the security.

3

New this quarter

Holders whose previous filing (at most two quarters earlier) did not report the security.

1

Exited this quarter

Tracked managers whose previous filing reported the security and whose filing for the quarter does not.

$3.8m

Inflow, new holders

Combined value of the positions the new holders reported for the quarter.

$68.5k

Outflow, exits

Combined value the exiting managers reported for the security in their previous filing.

$7.2m

Combined value

Sum of the holders' reported positions in the security.

0.5%

Share of managers holding

Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.